Relmada Therapeutics, Inc. (RLMD)
NASDAQ: RLMD · Real-Time Price · USD
0.6986
-0.0099 (-1.40%)
At close: Jun 3, 2025, 4:00 PM
0.7089
+0.0103 (1.47%)
After-hours: Jun 3, 2025, 5:41 PM EDT
Relmada Therapeutics Employees
Relmada Therapeutics had 17 employees as of December 31, 2024. The number of employees decreased by 3 or -15.00% compared to the previous year.
Employees
17
Change (1Y)
-3
Growth (1Y)
-15.00%
Revenue / Employee
n/a
Profits / Employee
-$4,453,570
Market Cap
23.19M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AbbVie | 55,000 |
RLMD News
- 22 days ago - Relmada Therapeutics, Inc. (RLMD) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 22 days ago - Relmada Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update - GlobeNewsWire
- 26 days ago - Relmada Therapeutics to Report First Quarter 2025 Financial Results on Monday, May 12, 2025 - GlobeNewsWire
- 5 weeks ago - Relmada Therapeutics Presents Positive Initial Phase 2 NDV-01 Data at AUA2025 - GlobeNewsWire
- 5 weeks ago - UPDATE -- Relmada Therapeutics To Present NDV-01 Data at AUA2025 - GlobeNewsWire
- 5 weeks ago - Relmada Therapeutics to Host KOL Event on Phase 2 NDV-01 Data - GlobeNewsWire
- 7 weeks ago - Relmada Therapeutics To Present NDV-01 Data at AUA2025 - GlobeNewsWire
- 2 months ago - Relmada Therapeutics, Inc. (RLMD) Q4 2024 Earnings Call Transcript - Seeking Alpha